Authors:
WILKE WS
FOUADTARAZI FM
CASH JM
CALABRESE LH
Citation: Ws. Wilke et al., THE CONNECTION BETWEEN CHRONIC-FATIGUE-SYNDROME AND NEURALLY-MEDIATEDHYPOTENSION, Cleveland Clinic journal of medicine, 65(5), 1998, pp. 261-266
Citation: Ws. Wilke et al., THE CLINICAL UTILITY OF THE HISTOPATHOLOGY HEALED ARTERITIS OF THE SUPERFICIAL TEMPORAL ARTERY (STA), Arthritis and rheumatism, 41(9), 1998, pp. 517-517
Citation: Ws. Wilke et Jm. Cash, THE USE OF SLOWER-ACTING (CLASS-III) SYMPTOM-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS, CLINICAL IMMUNOTHERAPEUTICS, 5(4), 1996, pp. 309-325
Citation: Hy. Chow et al., PATIENTS WITH CHRONIC FATIGUE SYNDROME (CFS) AND SILICONE-ASSOCIATED ILLNESS (SAI) ARE SIMILARLY DISABLED, Arthritis and rheumatism, 39(9), 1996, pp. 151-151
Citation: Ws. Wilke et Gs. Hoffman, TREATMENT OF CORTICOSTEROID-RESISTANT GIANT-CELL ARTERITIS, Rheumatic diseases clinics of North America, 21(1), 1995, pp. 59-71
Citation: Jm. Cash et Ws. Wilke, GUIDELINES FOR ROUTINE LIVER-BIOPSY DURING METHOTREXATE TREATMENT, Cleveland Clinic journal of medicine, 61(4), 1994, pp. 317-318
Citation: Ws. Wilke et al., EARLY, AGGRESSIVE THERAPY FOR RHEUMATOID-ARTHRITIS - CONCERNS, DESCRIPTIONS, AND ESTIMATE OF OUTCOME, Seminars in arthritis and rheumatism, 23(2), 1993, pp. 26-41
Citation: Gf. Duna et al., A GRADUATED STEP THERAPY PARADIGM FOR THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) - PRELIMINARY-RESULTS, Arthritis and rheumatism, 36(9), 1993, pp. 190000269-190000269